Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$542K Sell
5,819
-952
-14% -$84.3K 0.01% 1983
2025
Q4
$544K Buy
+6,771
New +$567K 0.01% 1514
2024
Q2
Sell
-6,670
Closed -$744K 1797
2024
Q1
$744K Buy
6,670
+958
+17% +$114K 0.1% 269
2023
Q4
$741K Buy
5,712
+2,820
+98% +$389K 0.16% 88
2023
Q3
$472K Buy
+2,892
New +$509K 0.08% 437
2023
Q2
Sell
-3,343
Closed -$445K 1361
2023
Q1
$445K Sell
3,343
-693
-17% -$81.4K 0.09% 366
2022
Q4
$320K Buy
+4,036
New +$284K 0.07% 542
2022
Q1
Sell
-3,055
Closed -$228K 637
2021
Q4
$228K Buy
+3,055
New +$181K 0.13% 313

Other funds holding ACLS

XTX Topco's ACLS Position: Q1 2026 in Review

XTX Topco reduced its Axcelis (ACLS) stake by 14% in Q1 2026, selling an estimated $84.3K and leaving 5,819 shares worth $542K. The position accounts for 0.01% of the portfolio, ranked #1983.

XTX Topco first reported a position in ACLS in Q4 2021 and has held it in 8 quarters since. The position peaked at $744K in Q1 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • XTX Topco held 5,819 shares of Axcelis worth $542K as of Q1 2026.
  • XTX Topco sold 952 Axcelis shares in Q1 2026, an estimated $84.3K.
  • Axcelis made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1983 holding.
  • XTX Topco first reported a position in Axcelis in Q4 2021 and has held it in 8 quarters since.
  • XTX Topco's Axcelis position peaked at $744K in Q1 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.